Exactly right. Trials by jury can be very unpredictable and very expensive, as this case indicates.
Why risk $22 million if you can get away with $5 or $10 million ?
Juries love David and Goliath situations.
Cordis Hit With $22M Verdict In Stent Patent Case
Law360, New York (February 05, 2009) -- A federal jury has found that Johnson & Johnson unit Cordis Corp. infringed a patent for a stent-cutting machine held by Spectralytics Inc. and awarded the latter company $22.35 million.
The jury in U.S. District Court for the District of Minnesota returned its verdict Monday, following a trial that began on Jan. 13. The jury found that the infringement of...